Class information for:
Level 1: APLASTIC ANEMIA//SEVERE APLASTIC ANEMIA//APLASTIC ANAEMIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3796 1830 30.5 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
233 19645 BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 APLASTIC ANEMIA Author keyword 240 43% 23% 427
2 SEVERE APLASTIC ANEMIA Author keyword 104 72% 4% 82
3 APLASTIC ANAEMIA Author keyword 73 45% 7% 121
4 ACQUIRED APLASTIC ANEMIA Author keyword 50 88% 1% 23
5 ANTI THYMOCYTE GLOBULIN Author keyword 27 26% 5% 90
6 IMMUNOSUPPRESSIVE THERAPY Author keyword 10 11% 5% 86
7 SEVERE LAST ANEMIA STUDYING PROGRAM Address 8 75% 0% 6
8 ANTILYMPHOCYTE GLOBULIN Author keyword 8 39% 1% 15
9 BONE MARROW FAILURE Author keyword 7 17% 2% 37
10 APLASTIC Author keyword 7 39% 1% 13

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 APLASTIC ANEMIA 240 43% 23% 427 Search APLASTIC+ANEMIA Search APLASTIC+ANEMIA
2 SEVERE APLASTIC ANEMIA 104 72% 4% 82 Search SEVERE+APLASTIC+ANEMIA Search SEVERE+APLASTIC+ANEMIA
3 APLASTIC ANAEMIA 73 45% 7% 121 Search APLASTIC+ANAEMIA Search APLASTIC+ANAEMIA
4 ACQUIRED APLASTIC ANEMIA 50 88% 1% 23 Search ACQUIRED+APLASTIC+ANEMIA Search ACQUIRED+APLASTIC+ANEMIA
5 ANTI THYMOCYTE GLOBULIN 27 26% 5% 90 Search ANTI+THYMOCYTE+GLOBULIN Search ANTI+THYMOCYTE+GLOBULIN
6 IMMUNOSUPPRESSIVE THERAPY 10 11% 5% 86 Search IMMUNOSUPPRESSIVE+THERAPY Search IMMUNOSUPPRESSIVE+THERAPY
7 ANTILYMPHOCYTE GLOBULIN 8 39% 1% 15 Search ANTILYMPHOCYTE+GLOBULIN Search ANTILYMPHOCYTE+GLOBULIN
8 BONE MARROW FAILURE 7 17% 2% 37 Search BONE+MARROW+FAILURE Search BONE+MARROW+FAILURE
9 APLASTIC 7 39% 1% 13 Search APLASTIC Search APLASTIC
10 ANEMIA APLASTIC 6 50% 0% 9 Search ANEMIA++APLASTIC Search ANEMIA++APLASTIC

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SAA WORKING PARTY 328 92% 7% 129
2 ANTILYMPHOCYTE GLOBULIN 246 69% 11% 209
3 ANTI THYMOCYTE GLOBULIN 156 31% 23% 427
4 IMMUNOSUPPRESSIVE THERAPY 37 15% 12% 228
5 ALTERNATIVE DONOR 36 83% 1% 20
6 LYMPHOKINE OVERPRODUCTION 18 83% 1% 10
7 ALEMTUZUMAB PLUS CYCLOSPORINE 17 100% 0% 8
8 ALTERNATIVE DONOR TRANSPLANTS 15 82% 0% 9
9 ANTI LYMPHOCYTE GLOBULIN 15 77% 1% 10
10 GRANULOCYTE STIMULATING FACTOR 15 88% 0% 7

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Guidelines for the diagnosis and management of aplastic anaemia 2009 152 136 63%
Current concepts in the pathophysiology and treatment of aplastic anemia 2006 242 107 80%
How I treat acquired aplastic anemia 2012 57 102 87%
Immunosuppressive therapy for transplant-ineligible aplastic anemia patients 2015 1 96 86%
Mechanisms of disease - The pathophysiology of acquired aplastic anemia 1997 255 61 67%
Idiopathic aplastic anemia: Diagnosis and classification 2014 6 34 82%
Acquired aplastic anemia 2002 137 46 67%
Front-line immunosuppressive treatment of acquired aplastic anemia 2013 8 21 95%
Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders 2015 2 69 28%
Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression 2013 10 16 75%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SEVERE LAST ANEMIA STUDYING PROGRAM 8 75% 0.3% 6
2 COMPREHENS BONE MARROW FAILURE 6 80% 0.2% 4
3 ANEMIA THER EUT 4 75% 0.2% 3
4 HAEMATOL SCT UNIT 3 100% 0.2% 3
5 ADULT HSCT PROGRAM 2 67% 0.1% 2
6 HEMATOL 2 1 17% 0.4% 8
7 MARROW FAILURE MYELODYSPLASIA PROGRAM 1 31% 0.2% 4
8 PAEDIAT ADOLESCENT HAEMATOL 1 100% 0.1% 2
9 HAEMATOL 2 1 24% 0.3% 5
10 STEM CELL PLICAT UNIT 1 25% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000147165 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA//PNH//PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
2 0.0000083444 B B RAT//CFU SD8//BURST PROMOTING ACTIVITY
3 0.0000079066 PURE RED CELL APLASIA//T CELL LARGE GRANULAR LYMPHOCYTE LEUKEMIA//LARGE GRANULAR LYMPHOCYTE LEUKEMIA
4 0.0000069899 INT TRANSPLANTAT THALASSEMIA SICKLE CELL AN//MEDITERRANEAN HEMATOL//TR IANTO MIDOLLO OSSEO MURAGLIA
5 0.0000067128 AUTOIMMUNE MYELOFIBROSIS//DACRYOCYTES//ABNORMAL LOCALIZATION OF IMMATURE PRECURSORS ALIP
6 0.0000063232 DYSKERATOSIS CONGENITA//HOYERAAL HREIDARSSON SYNDROME//DYSKERIN
7 0.0000054076 AGRANULOCYTOSIS//DRUG INDUCED AGRANULOCYTOSIS//EVALUATION SCORE
8 0.0000052970 HAPLOIDENTICAL//NORMAL DONORS//T CELL DEPLETION
9 0.0000052615 TOTAL BODY IRRADIATION//TOTAL MARROW IRRADIATION//OCULAR GRAFT VERSUS HOST DISEASE
10 0.0000051093 DONOR CELL LEUKEMIA//CHIMERISM//STR PCR